Recent development of new muscle relaxants, atracurium, vecuronium, and doxacurium, has met most of the goals outlined by Savarese and Kitz t for the ideal muscle relaxant with an intermediate or long duration of action, but the search continues for a drug with rapid onset and short duration of action. This nondepolarizing drug should be noncumulative and should have a rapid, spontaneous recovery. Succinylcholine is frequently used when rapid onset and short duration of neuromuscular blockade are desired. Its usefulness is limited by a number of side effects mainly related to its depolarizing nature of action. 2-4 Most of these, with the exception of muscle pains, are infrequent but potentially serious.
clinical studies in human volunteers and healthy surgical patients indicated that the neuromuscular effects of mivacurium are of short duration and readily reversed with anticholinesterase. 5-11 The purpose of this study was to evaluate the neuromuscular and cardiovascular effects of a wide range of doses of mivacurium during either nitrous oxide-narcotic anaesthesia or nitrous oxideisoflurane anaesthesia in healthy patients requiring elective surgery. In addition, the neuromuscular blocking properties were compared with those of succinylcholine.
Methods and materials
One hundred forty-four ASA physical status I or II patients, aged 18-70 years, weighing 40-110 kg, who required elective surgery, were studied after written informed consent was obtained. The protocol for the study was approved by the University of Iowa Human Research Committee. Patients were excludedfrom the study if they had a history of (1) malignant hyperthermia; (2) unusual sensitivity to neuromuscular-blocking agents; (3) alcohol or drug abuse; (4) psychiatric, neuromuscular or severe cardiovascular disease, or impaired renal or liver function; (5) asthma; (6) exposure to aminoglycoside antibiotics, quinidine, lidocaine, or trimethaphan within 48 hr of the study; (7) exposure to antihistamines or antidepressants within one week of the study; (8) ECG abnormalities; or (9) child-bearing potential.
Premedication included morphine (0.05-0.15 mg' kg -t, IM), atropine (0.004-0.008 mg.kg -1, IM), or diazepam (0.1-0.2 mg-kg-l, PO) 30-90 min before the induction of anaesthesia. In the operating room, five per cent dextrose in lactated Ringer's solution was administered via an intravenous catheter.
A force displacement transducer (Grass Fr-10) was used to measure and record the twitch response of the adductor pollicis muscle to ulnar nerve stimulation. The ulnar nerve was stimulated at the wrist using two 25-gauge subcutaneous needles. A Grass stimulator delivered square wave pulses at 0.15 Hz, 0.2 msec duration, and supramaximal voltage (20 V above maximum response). The twitch response of the adductor pollieis elicited by ulnar nerve stimulation and heart rate by ECG were recorded continuously on a HewlettPackard four channel recorder. Blood pressure was monitored throughout the study with an automated oscilIotonometer for estimated drug doses less than ED95 or an intra-arterial catheter for drug doses estimated to be ED9s or greater. The method for development of the doseresponse relationship and ED95 doses for these patients is described later. In those patients who bad direct blood pressure measured, blood pressure was continuously monitored and displayed on the four channel recorder. Heart rate and systolic, diastolic, and mean arterial pressures were recorded every minute beginning two minutes before drug administration and continuing for ten minutes following injection of the drug. Direct arterial pressure measurements were continuously recorded over the same time period.
Mass spectromea'y (Perkin Elmer) was used to measure end-tidal CO2 and ventilation was controlled or assisted to maintain end-tidal PCO2 in a range of 35-45 mmHg. Temperature was maintained at 36.5 ---0.5 ~ C.
The 144 patients were divided into three groups. In 90 patients (ten subgroups with nine patients each (fentanyl 1-10)) mivacurium was administered as a single bolus dose during nitrous oxide, oxygen and narcotic anaesthesia (fentanyl). Forty-five patients who were divided into five subgroups (ISO 1-5) received mivacurium during nitrous oxide, oxygen and isoflurane anaesthesia (1SO). Nine patients received succinycholine (SCH) during N2O-narcotic anaesthesia (Table I) .
In the fentanyl and SCH groups anaesthesia was induced with thiopentone (3-4 mg' kg-') and maintained with 60-70 per cent nitrous oxide in oxygen and fentanyl (2-10 ~g. kg-i). Supplemental doses of thiopentone and fentanyl were administered to maintain anaesthesia. In the ISO group anaesthesia was maintained with nitrous oxide (60-70 per cent) in oxygen and isoflurane (end tidal concentration maintained for 10 min, 0.7 per cent) analyzed by a mass spectrometer. After establishing a baseline neuromuscular response, 15 minutes after induction of anaesthesia, a predetermined dose of mivacurium was injected rapidly over 2-3 sec into a free flowing intravenous catheter. Tracheal intubation, when indicated, was performed either 10 min following mivacurium injection or after the termination of collection of all haemodynamic data.
Patients in the first four fentanyl subgroups (fentanyl 1-4) were used to determine a dose-response relationship for mivacurium. Subgroup fentanyl 1 received an initial dose of 0.03 mg' kg-', a dose anticipated to be equivalent to ED~ from previous data. s The dose administered to fentanyl 2 was based on the response of fentanyl 1 and the assumption that the slope of the dose-response curve would be approximately that seen in Basta's study. 5 Subsequent doses were based on the responses and slope of the regression of fentanyl 1 and fentanyl 2. The ED95 was derived by linear regression analysis of the preceding three fentanyl subgroups.
The doses for subgroup fentanyl 5 was 2.0 x EDgs, fentanyl 6 and 7 was 2.5 x ED95 , and 8, 9, 10 received 3 x ED95 as determined from the dose response relations data obtained from subgroups fentanyl 1-4. In all but one of the subgroups (fentanyl 9) muscle twitch was allowed to recover to 95 per cent of control following the initial dose. Spontaneous recovery from NMB was evaluated as time from injection to 5, 25 and 95 per cent of control twitch height. Recovery index is the time requited for recovery to proceed from 25 to 75 per cent of the control value. To assess ease of using a continuous infusion, patients in fentanyl 4, fentanyl 6, fentanyl 8 and fentanyl 10 received a second bolus dose, 0.1 mg .kg -~, to produce complete neuromuscular block and when the neuromuscular block recovered to approximately five per cent of control response, a continuous infusion was initiated and adjusted to maintain neuromuscular blockade within 95 -+ 4 per cent for the duration of the surgical procedure. The initial infusion rate of mivacurium was 10 p.g.kg -~. rain -I ' Cumulative properties of mivacurium were evaluated in patients in fentanyl 9. After recovery of the twitch response to 95 per cent of control following the initial dose, 0.25 mg'kg -~, a second dose was administered to produce complete neuromuscular block. A minimum of four fixed doses of mivacurium, 0.1 mg'kg -t, were administered sequentially at 5-10 per cent twitch response recovery in each patient. Onset, magnitude, and duration of the block that occurred following each supplemental dose were evaluated.
Pharmacological reversal of mivacurium was studied in 11 patients. In these patients spontaneous recovery was observed to ten per cent of control twitch response at which time pharmacological reversal of neuromuscular block was accomplished with atropine 0.015 mg .kg -t and neostigmine 0.03 mg" kg -j . The times required for > 95 per cent recovery of twitch response and train-of-four ratio -> 0.75 were recorded and compared with spontaneous recovery.
The cardiovascular effects of rapid large bolus doses, .3,5 and 3 • ED9s, of mivacurium were evaluated in fentanyl 6-10. In fentanyl 6, 8, 9 mivacurium was injected as a rapid bolus over 2-3 sec, while in fentanyl 7 and fentanyl 10 the same dose was injected over a 30-see period.
The influence of isoflurane anaesthesia on neuromuscular blockade was studied in 45 patients who were anaesthetized with 60-70 per cent N20 and 0.7 per cent isoflurane. Three of the five groups, ISO 1-3, were used to establish a dose-response relationship. Groups ISO 4 and ISO 5 received doses of 1.0 x EDgs, and 2 • EDgs. The initial dose, 0.03 mg.kg -1, was derived from our data with fentanyl anaesthesia. The second dose was based on the response of the first dose assuming that slopes of the dose-response curves under isoflurane and narcotic anaesthesia were similar. Remaining doses were derived from the response to the first two doses as described for patients in the fentanyl group. Comparisons with succinylcholine chloride were made in a group of nine patients that received 1.0 mg.kg-i of suecinylcholine as a bolus IV during N20/O2 fentanyl anaesthesia. Following the initial dose of succinylcholine, the muscle twitch response was allowed to recover to approximately five to ten per cent of baseline value, at which time a continuous IV infusion of succinylcholine, 60-120 ~g, kg-t" min, was begun to maintain 95 • 4 per cent twitch suppression throughout the surgical procedure.
The magnitude of block, time to achieve maximum block, and time for twitch recovery to 25, 75, and 95 per cent of control, as well as time for train-of-four ratio (applied when twitch tension reached 95 per cent recovery) -> 0.75 were recorded. In all patients the magnitude of block and initial recovery were expressed as per cent of the twitch tension before drug administration (precontrol). This value was also used to determine the percentage of block at which supplemental doses or drug infusions were administered. When final recovery twitch tension, at which train-of-four ratio was greater than 0.75, was less than 95 per cent of the initial control, the final value (post control) was used for calculating recovery index and other recovery values.
Blood samples for plasma histamine concentration were obtained immediately before and at two and five minutes following mivacurium administration in subgroups fentanyl 6-10. They were analyzed according to a refinement of the radioenzymatic method ~ originally described by Moss et al. 22 An additional blood sample was obtained in each patient for determination of plasma cholinesterase activity and dibucaine number. The correlations between the duration of action of various doses of mivacurium and the plasma cholinesterase activity and dibucaine number were studied in 54 patients, who recovered spontaneously to 95 per cent of control.
In the recovery room patients were evaluated at 30 min intervals until discharge to evaluate the continued adequacy of muscle strength as determined by adequate hand grip and ability to sustain head lift for five seconds.
Dose-response relationships were developed using the probit log dose method of Litchfield and Wilcoxon. j2 Linear regression techniques were used to assess the relationship between the probit transformation of per cent block and the logarithm of dose. The dose-response data for time to maximum block and duration of neuromuscular block were also analyzed using linear regression. For both of these dependent variables, the replicate observations at each dosage were used to test the linearity of the regression relationship. 13 Time trends for the cardiovascular variables, MAP, HR, were assessed using multivariate analysis of variance. 14 The relationships between duration of block and plasma cholinesterase activity and dibucaine number were assessed using nonparametric (Spearman) correlation coefficients, ts P -< 0.05 was considered significant. Values are expressed as mean + SEM.
Results
Division of study patients into groups, drug doses used, type of anaesthesia and recovery are shown in Table I . Mivacurium produced a dose-dependent neuromuscular block in patients receiving both nitrous oxide narcotic and nitrous oxide isoflurane anaesthesia. In those patients given fentanyl anaesthesia, 0.080 mg'kg -~ produced (Table 111 ). There was no significam difference in RI among the first and last doses in repeated bolus administration or continuous infusion of mivacurium. Following the initial bolus dose of suceinylcholine, 1.0 mg. kg -l, a continuous infusion of succinylcholine was adjusted to maintain twitch response at five to ten per cent of control. At the end of continuous succinylcholine infusion, the recovery index was 6.81 • 1.8 min (Table  IV) . Reversal of mivacurium induced neuromuscular block was accomplished with atropine 0.015 mg.kg -~ and neostigmine 0.03 mg. kg-i, following single and repeatad bolus and continuous infusion (Table III) .
Fifteen patients had a low plasma cholinesterase activity (less than 2.3 p.m" ml -~" min -]) and one patient had a low dibucaine number (Figure 4 A,B) . There was no significant correlation between the duration of action of mivacurium and the plasma cholinesterase activity of patients studied( Figure 4A, B) . There was no clinically significant change in mean arterial pressure or heart rate following bolus doses of mivacurium up to and including 0.15 mg.kg -1 in any anaesthetic group (Fig 5 A,B,C,D) . Bolus administration of mivacurium, 0.20 or 0.25 rag. kg -t , produced significant decreases in MAP from 78.2 -2.5 to 64.0 • 3.2 mmHg (range 12-59 per cent of control) in 52 per cent or 14 out of 27 patients within two minutes. This change was of short duration and within five minutes MAP was within ten per cent of control in all but one patient (fentanyl/ pt. #69). This patient required treatment for haemodynamie instability (ephedrine 10 mg, IV). Four patients in the 0.20 mg. kg-1, fentanyl 6, and six patients in the 0.25 mg.kg -1, fentanyl 8, groups had a cutaneous flush following rapid administration of mivacurium and corresponding increased histamine levels ( Table V) . The same doses of mivacurium administered slowly over 30 see produced no clinically significant change in mean arterial pressure. There was no clinically significant change in heart rate at any time in all doses studied.
Discussion
In this study, a dose-response relationship was established for the neuromuscular actions of mivacurium in humans under either fentanyl or ISO anaesthesia. With this drug, time to onset, magnitude and duration of maximal block The influence of ISO anaesthesia on mivacuriuminduced neuromuscular block when compared with fentanyl anaesthesia in this study is different from the work of Weber. 7 The difference in dose response during isoflurane and fentanyl anaesthesia in this study may suggest a different mechanism of neuromuscular block produced by mivacurium during isoflurane anaesthesia compared with fentanyl anaesthesia. It is, however, more likely to be due to individual variability in response to drug and a small sample size or both. Patients anaesthetized with nitrous oxide-narcotic show a markedly variable response to tow-dose neuromusculax blocking agent. ~ s In one patient in the fentanyl group a dose of 0.3 mg.kg -I, ED25, produced 80 per cent twitch suppression. The calculated ED95 of mivacurium with ISO and fentanyl anaesthesia was similar to those of other studies. 6'7
The mean recovery index, defined as the time required for 25 to 75 per cent recovery, following administration of repeated fixed doses of mivacurium (7.58 ---0.67 min) or continuous infusion (6.66 -+ 0.73 min), was similar to the mean recovery index of the initial dose (6.10 -+-0.47). We interpret this as suggesting that little or no pharmacodynamic cumulative effect occurs during repeated doses of mivacurium. This may be due to rapid hydrolysis of mivacurium by plasma cholinesterase. ~ The recovery index following a continuous infusion of mivacurium (6.66 -+ 0.73 rain) is comparable with that following an infusion of succinylcholine (6.80 --1.80 min). Our data support that of All et al. i9 who suggested that the recovery index following a mivacurium infusion is more predictable than recovery following succinylcholine, when infusions of similar duration producing similar degrees of neuromuscular block are compared. The variable recovery after a succinylcholine infusion may be related to the drug's potential to produce phase II block.20. 21
Since spontaneous recovery from mivacurium-induced block was rapid, antagonism of residual mivaeuriuminduced block would seem necessary less frequently than following administration of other nondepolarizing agents. Reversal of mivacurium-induced block was accomplished with atropine 0.015 m g . k g -' and neostigmine 0.03 mg.kg -1 following a single dose, repeated boluses or continuous infusion.
The poor correlation between plasma cholinesterase activity and duration of action of mivacurium in individual subjects in this study may be attributed to relatively small variance of cholinesterase activity in this group of patients or another route of metabolism and/or excretion of mivacurium. These observations are similar to those of Savatese et all ' The cardiovascular effects (mean arterial blood pressure, heart rate) of mivacurium is minimal with the doses up to approximately 2 x ED95 during either anaesthetic technique. This is supporting evidence that the drug has little autonomic stimulating or blocking effect with low doses. Bolus administration of large doses (> 2.5 x EDgs) of mivacurium produced a significant, but transient, decrease in blood pressure. The same dose of drug, when administered slowly, caused no significant cardiovascular change. If drug-induced histamine release is closely related to the peak plasma level achieved, z2 then a drug that is rapidly cleared might be expected to release less histamine when administered slowly.
Mivacurium is a neuromuscular blocking agent which has a short duration of action without cumulative effects and minimal cardiovascular change in doses up to 2 • ED95. Large bolus doses (> 2.5 x ED95) of mivacurium produced a significant decrease in MAP and a corresponding increase in histamine levels.
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